MedPass International, founded in 1991, is a leading player in the biotechnology and healthcare industries. The company specializes in Clinical Development, Regulatory Strategies, and EU Market Access for Medical Devices. MedPass offers a comprehensive suite of services, including strategic consulting, CRO and biometrics services, regulatory affairs, and access market pricing and reimbursement. The company positions itself as a "one stop shop" for medical device manufacturers seeking access to the EU market. With a focus on being the preferred partner for navigating the complex EU regulatory landscape, MedPass International stands out as a key player in facilitating market entry for medical devices. Currently, there is no public information available about the latest investment or the involved investors for MedPass International.
There is no investment information
No recent news or press coverage available for MedPass International.
We care about your data, and we'd love to use cookies make your experience better.